Ionis Pharmaceuticals Earns $2.15M Milestone from Biogen for Completing Target Enrollment of Phase 3 CHERISH Study
January 12, 2016 at 07:06 AM EST
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it has earned a milestone payment of $2.15 million from Biogen for ...
